GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Shandong Sanyuan Biotechnology Co Ltd (SZSE:301206) » Definitions » Debt-to-Equity

Shandongnyuan Biotechnology Co (SZSE:301206) Debt-to-Equity : 0.00 (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shandongnyuan Biotechnology Co Debt-to-Equity?

Shandongnyuan Biotechnology Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥0.0 Mil. Shandongnyuan Biotechnology Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥0.0 Mil. Shandongnyuan Biotechnology Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥4,562.3 Mil. Shandongnyuan Biotechnology Co's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Shandongnyuan Biotechnology Co's Debt-to-Equity or its related term are showing as below:

SZSE:301206's Debt-to-Equity is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 0.41
* Ranked among companies with meaningful Debt-to-Equity only.

Shandongnyuan Biotechnology Co Debt-to-Equity Historical Data

The historical data trend for Shandongnyuan Biotechnology Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandongnyuan Biotechnology Co Debt-to-Equity Chart

Shandongnyuan Biotechnology Co Annual Data
Trend Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only - - - - -

Shandongnyuan Biotechnology Co Quarterly Data
Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Shandongnyuan Biotechnology Co's Debt-to-Equity

For the Confectioners subindustry, Shandongnyuan Biotechnology Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandongnyuan Biotechnology Co's Debt-to-Equity Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Shandongnyuan Biotechnology Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Shandongnyuan Biotechnology Co's Debt-to-Equity falls into.



Shandongnyuan Biotechnology Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Shandongnyuan Biotechnology Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shandongnyuan Biotechnology Co's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandongnyuan Biotechnology Co  (SZSE:301206) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Shandongnyuan Biotechnology Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Shandongnyuan Biotechnology Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandongnyuan Biotechnology Co (SZSE:301206) Business Description

Traded in Other Exchanges
N/A
Address
No. 89, Zhangfu Road, Binbei, Shandong Province, Binzhou, CHN, 256600
Shandong Sanyuan Biotechnology Co Ltd is engaged in providing consumers with new and healthier sweeteners.
Executives
Nie Zai Jian Director
Cheng Bao Hua Executives
Cui Zhen Qian Supervisors

Shandongnyuan Biotechnology Co (SZSE:301206) Headlines

No Headlines